ANDANTE

Multidisciplinary evaluation of the cancer risk from neutrons relative to photons using stem cells and the induction of second malignant neoplasms following paediatric radiation therapy

 Coordinatore UNIVERSITA DEGLI STUDI DI PAVIA 

 Organization address address: STRADA NUOVA 65
city: PAVIA
postcode: 27100

contact info
Titolo: Dr.
Nome: Maria
Cognome: Brunelli
Email: send email
Telefono: +39 0382 987577
Fax: +39 0382 987752

 Nazionalità Coordinatore Italy [IT]
 Totale costo 4˙465˙913 €
 EC contributo 3˙000˙000 €
 Programma FP7-EURATOM-FISSION
EURATOM: Nuclear fission and radiation protection
 Code Call FP7-Fission-2011
 Funding Scheme CP-FP
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-01-01   -   2015-12-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSITA DEGLI STUDI DI PAVIA

 Organization address address: STRADA NUOVA 65
city: PAVIA
postcode: 27100

contact info
Titolo: Dr.
Nome: Maria
Cognome: Brunelli
Email: send email
Telefono: +39 0382 987577
Fax: +39 0382 987752

IT (PAVIA) coordinator 940˙000.00
2    ACADEMISCH ZIEKENHUIS GRONINGEN

 Organization address address: Hanzeplein 1
city: GRONINGEN
postcode: 9713 GZ

contact info
Titolo: Ms.
Nome: Johanna M
Cognome: Van Apeldoorn
Email: send email
Telefono: 31503633040
Fax: 31503632883

NL (GRONINGEN) participant 605˙000.00
3    UNIVERSITAET ROSTOCK

 Organization address address: UNIVERSITATSPLATZ 1
city: ROSTOCK
postcode: 18051

contact info
Titolo: Prof.
Nome: Guido
Cognome: Hildebrandt
Email: send email
Telefono: +49 381 494 9001
Fax: +49 381 494 9002

DE (ROSTOCK) participant 575˙000.00
4    PAUL SCHERRER INSTITUT

 Organization address address: Villigen
city: VILLIGEN PSI
postcode: 5232

contact info
Titolo: Ms.
Nome: Irene
Cognome: Walthert
Email: send email
Telefono: +4156 3102664
Fax: +4156 3102717

CH (VILLIGEN PSI) participant 350˙000.00
5    BUNDESAMT FUER STRAHLENSCHUTZ

 Organization address address: Willy-Brandt-Strasse 5
city: SALZGITTER
postcode: 38226

contact info
Titolo: Ms.
Nome: Susan
Cognome: Fischer
Email: send email
Telefono: +49 30 18 333 1537
Fax: +49 30 18 333 1525

DE (SALZGITTER) participant 150˙000.00
6    CHALMERS TEKNISKA HOEGSKOLA AB

 Organization address address: -
city: GOETEBORG
postcode: 41296

contact info
Titolo: Ms.
Nome: Hofling
Cognome: Hofling
Email: send email
Telefono: +46 31 7723208

SE (GOETEBORG) participant 142˙884.00
7    LOMA LINDA UNIVERSITY

 Organization address city: LOMA LINDA
postcode: 92350

contact info
Titolo: Mr.
Nome: Arlin
Cognome: Tueller
Email: send email
Telefono: +1 909 558 4589
Fax: +1 909 558 0199

US (LOMA LINDA) participant 120˙000.00
8    EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY

 Organization address address: Avenue E Mounierlaan 83
city: BRUXELLES
postcode: 1200

contact info
Titolo: Ms.
Nome: Evelyn
Cognome: Chimfwembe
Email: send email
Telefono: 3227759340

BE (BRUXELLES) participant 100˙000.00
9    TECHNISCHE UNIVERSITAET WIEN

 Organization address address: Karlsplatz 13
city: WIEN
postcode: 1040

contact info
Titolo: Dr.
Nome: Stephan
Cognome: Schneider
Email: send email
Telefono: 43158800000000
Fax: 4315880000000

AT (WIEN) participant 17˙116.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

photons    secondary    analysed    gland    uses    icrp    breast    cell    epidemiology    irradiated    risks    dose    radiobiology    carlo    international    beams    molecular    radiation    exposure    data    protection    epidemiological    malignant    cancer    paediatric    therapy    thyroid    risk    determine    irradiation    relative    physics    neutrons    spectrum    cancers    andante    photon    biology    salivary    proton    neoplasms    estimate    cells    energy    model    neutron    radiotherapy    tissue    monte    stem    simulation    either   

 Obiettivo del progetto (Objective)

'The ANDANTE project will investigate the relative risk of neutrons compared to photons for tumorigenesis, as a function of dose and energy. The approach will be multidisciplinary, including physics measurements and modelling, molecular biology, radiobiology, and epidemiology. The relative risk of neutrons will be studied using human and animal stem cells irradiated with either photons or neutrons in vitro and analysed for early indicators of malignant transformations. Irradiated stem cells will be transplanted into mice to investigate progression into tumours. The experimental irradiation setup will be fully characterised and modelled in order to compare predicted molecular damage with biological results, following controlled irradiation with either photons or neutrons. A corresponding predictive model of the relative risk of cancer induction from photons or neutrons following paediatric radiotherapy will be developed and tested on clinical data, as a proof of principle, leading to a proposal for a prospective epidemiological study to validate the relative risk of neutrons on humans.'

Introduzione (Teaser)

Neutrons are generated as a by-product in high-energy photon beams or proton beams during radiotherapy. There is a growing concern about associated possible long-term risks to radiotherapy patients.

Descrizione progetto (Article)

The usual approach to risk assessment from neutrons uses Monte Carlo simulation to estimate normal tissue exposure. It uses risk factors and radiation factors for neutrons published by the International Commission on Radiological Protection (ICRP). However, the ICRP risk factors are approximations to be used for radiation protection guidelines, and not for individual risk estimates.

The EU-funded http://www.andanteproject.eu/ (ANDANTE) international project will use radiation physics, stem cell radiobiology, systems biology modelling, and epidemiology to estimate cancer risk from exposure to neutrons. The project focuses on salivary gland, thyroid gland, and breast cancers as secondary malignant neoplasms following paediatric photon radiotherapy.

Consortium partners selected and prepared facilities for irradiation experiments. Initially a broad spectrum, high-dose-rate neutron beam will be used to determine stem cell response to neutrons. Based on the results, a further series will be carried out using low-dose, narrow spectrum beams to determine the dependence of response on neutron energy. The Monte Carlo simulation toolkit will be used to model the neutron fields generated by therapeutic proton machines.

Methods for the isolation of stem cells for salivary gland, thyroid gland, and breast tissue have been successfully developed. They are based on the formation of spheroids (multicellular 3D structures) which can be used in non-adherent cultivation as cell suspensions. The results of initial exposures of stem cell samples are currently being analysed.

Epidemiological studies of the risk of secondary malignant neoplasms occurring after radiotherapy for primary malignant neoplasms during childhood have been reviewed. The assembled data and the strategies used in these studies represent a starting point for the design of future epidemiological research in paediatric proton therapy.

The ANDANTE project will have a direct impact on the understanding of long term risks of secondary cancers following exposure to neutrons during proton therapy. It is expected to produce results that are important for any area of radiation protection where neutrons are a factor. This includes the nuclear power industry, high energy medical linear accelerators, and long-haul air flights.

Altri progetti dello stesso programma (FP7-EURATOM-FISSION)

CHANDA (2013)

solving CHAllenges in Nuclear DAta

Read More  

EUROPAIRS (2009)

End User Requirement fOr Process heat Applications with Innovative Reactors for Sustainable energy supply

Read More  

PELGRIMM (2012)

"PELlets versus GRanulates: Irradiation, Manufacturing & Modelling"

Read More